相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cross-Neutralization Potential of Native Human Papillomavirus N-Terminal L2 Epitopes
Michael J. Conway et al.
PLOS ONE (2011)
Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
Zigui Chen et al.
PLOS ONE (2011)
A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
Ebenezer Tumban et al.
PLOS ONE (2011)
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
Ivonne Rubio et al.
VIROLOGY (2011)
Vaccines to Prevent Infections by Oncoviruses
John T. Schiller et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
Whole-Genome Sequence Analysis of Human Papillomavirus Type 18 from Infected Thai Women
Woradee Lurchachaiwong et al.
INTERVIROLOGY (2010)
Abundance of Multiple High-Risk Human Papillomavirus (HPV) Infections Found in Cervical Cells Analyzed by Use of an Ultrasensitive HPV Genotyping Assay
Markus Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
Subhashini Jagu et al.
VACCINE (2010)
HPV Vaccines: Preclinical Development
Lutz Gissmann
ARCHIVES OF MEDICAL RESEARCH (2009)
Evolutionary Dynamics of Variant Genomes of Human Papillomavirus Types 18, 45, and 97
Zigui Chen et al.
JOURNAL OF VIROLOGY (2009)
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
Christina Schellenbacher et al.
JOURNAL OF VIROLOGY (2009)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
High-throughput detection and multiplex identification of cell contaminations
Markus Schmitt et al.
NUCLEIC ACIDS RESEARCH (2009)
The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding
Rhonda C. Kines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20-38) peptide displayed on bacterial thioredoxin
Ivonne Rubio et al.
VACCINE (2009)
Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions
Kazunari Kondo et al.
VIROLOGY (2009)
Human papillomavirus infection in Ulaanbaatar, Mongolia: A population-based study
Bolormaa Dondog et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers
Markus Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies
Patricia M. Day et al.
JOURNAL OF VIROLOGY (2008)
A protective and broadly cross-neutralizing epitope of human papillomavirus L2
Ratish Gambhira et al.
JOURNAL OF VIROLOGY (2007)
Clustal W and clustal X version 2.0
M. A. Larkin et al.
BIOINFORMATICS (2007)
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2
Ratish Gambhira et al.
JOURNAL OF VIROLOGY (2007)
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
Elmar A. Joura et al.
LANCET (2007)
Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV 16 minor capsid protein L2 surface region
Kazunari Kondo et al.
VIROLOGY (2007)
Bead-based multiplex genotyping of human papillomaviruses
M Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys:: a pooled analysis
GM Clifford et al.
LANCET (2005)
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18
DV Pastrana et al.
VIROLOGY (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types
ND Christensen et al.
VIROLOGY (2001)
NHPV16VLP vaccine induces human antibodies that neutralize divergent variants of HPV16
DV Pastrana et al.
VIROLOGY (2001)
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
XJS Chen et al.
MOLECULAR CELL (2000)